TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Drug Combinations
KW - Harm Reduction/drug effects
KW - Humans
KW - Methadone/therapeutic use
KW - Naloxone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/drug therapy
KW - Queensland
KW - Retrospective Studies
KW - Substance Abuse, Intravenous/drug therapy
KW - Substance-Related Disorders/drug therapy
AU - A. Smirnov
AU - R. Kemp
A1 - 
AB - Buprenorphine/naloxone has recently been introduced in Australia and is available for unsupervised dosing within Queensland. A retrospective observational study of data collected during 2000-2007 for clients obtaining injecting equipment from the Brisbane Harm Reduction Centre in Queensland is presented. The numbers of service occasions and needles and syringes were used as surrogate drug use measures. Buprenorphine and naloxone were misused at lower rates when compared with buprenorphine and methadone. Furthermore, the misuse of opioid replacement therapies represented less than 5% of all illicit opioid injections. Implications and study limitations are discussed.
BT - Substance use & misuse
C5 - Opioids & Substance Use
CP - 1
CY - England
DO - 10.3109/10826084.2011.629017
IS - 1
JF - Substance use & misuse
N2 - Buprenorphine/naloxone has recently been introduced in Australia and is available for unsupervised dosing within Queensland. A retrospective observational study of data collected during 2000-2007 for clients obtaining injecting equipment from the Brisbane Harm Reduction Centre in Queensland is presented. The numbers of service occasions and needles and syringes were used as surrogate drug use measures. Buprenorphine and naloxone were misused at lower rates when compared with buprenorphine and methadone. Furthermore, the misuse of opioid replacement therapies represented less than 5% of all illicit opioid injections. Implications and study limitations are discussed.
PP - England
PY - 2012
SN - 1532-2491; 1082-6084
SP - 78
EP - 85
EP - 
T1 - Use and misuse of opioid replacement therapies: A Queensland study
T2 - Substance use & misuse
TI - Use and misuse of opioid replacement therapies: A Queensland study
U1 - Opioids & Substance Use
U2 - 22216993
U3 - 10.3109/10826084.2011.629017
VL - 47
VO - 1532-2491; 1082-6084
Y1 - 2012
ER -